T1	Participants 80 117	patients with advanced breast cancer:
T2	Participants 380 431	in patients with breast cancer with bone metastases
T3	Participants 550 569	placebo (n = 1,026)
T4	Participants 657 676	placebo (n = 1,020)
T5	Participants 1685 1734	in patients with breast cancer metastatic to bone
T6	Participants 1909 1942	for patients with bone metastases
